Pressure-dependent In-Situ Monitoring of Granular Materials
颗粒材料的压力相关原位监测
基本信息
- 批准号:EP/S02168X/1
- 负责人:
- 金额:$ 66.19万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2019
- 资助国家:英国
- 起止时间:2019 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The majority of medicines are marketed as oral solid dosage forms and tablets in particular. The building blocks of each tablet include the active ingredient (or drug) and other components (excipients) that when formulated together confer stability, ease of handling and administration, patient compliance and assure delivery of the correct dose of medicine to patients in every tablet. These ingredients are typically presented in granular or powdered form, whether as individual particles, aggregates or formulated intermediates. This proposal seeks to couple an experimental process simulator with advanced measurement to improve our understanding of the relationship between the structure and properties of granular raw materials, compaction processes and the structure and final product performance. This will lead to a range of advances including: predictive or digital formulation design; rapid process development; and digital manufacturing. Consequently, these advances will accelerate the speed with which new medicines can reach the market and reduce costs, which is necessary if we are to realise the supply chains to meet patients' future medicines needs.New pharmaceutical products are far more complex than the standard immediate-release tablets that can be found in simple over-the-counter medicines. The development and manufacture of present-day drugs is much more demanding given the need to achieve target physicochemical and biopharmaceutical properties of the tablet which are themselves a function of more complex molecular and physical properties of the input materials. The advances in the chemistry of such new molecules are staggering, whilst the science that underpins the manufacturing methods used to formulate and produce them is still not very well understood for any given formulation. This necessitates new approaches and technologies to access chemical and physical performance-related material properties during manufacturing development.We will push the limits of existing techniques by integrating state-of-the-art terahertz time-domain spectroscopy into a high-end compaction simulator. This fully integrated system will be capable of monitoring the physical and chemical changes of granular materials during compaction into tablets in situ using terahertz technology. The system will provide an innovative and powerful research platform to address key research challenges in pharmaceutical sciences and manufacturing: analysis of phase transformations in pharmaceutical materials during compression (Theme 1), in-situ monitoring of bulk properties in formulated systems under pressure (Theme 2), digital design of oral pharmaceutical drug products (Theme 3). The outcomes of these research themes are ranging from predicting drug stability (Theme 1) and enabling direct compression by rapid formulation design (Theme 2) to predicting drug performance based on digital process and product design (Theme 3). The equipment will be housed within a well managed, state-of-the-art laboratory facility supported by a dedicated team of academic and support staff. This equipment will provide exciting opportunities for Strathclyde and other UK academics to collaborate and partner with other world-leading groups having complementary analytical facilities and manufacturing processes, thereby creating an international collaborative network of non-duplicated facilities for transnational access. Moreover, the equipment will generate new research opportunities in high value manufacturing, cutting-edge measurement technologies and advanced materials science in partnership with the National Physical Laboratory (NPL), Medicines Manufacturing Innovation Centre (MMIC), Centre for Process Analytics and Control Technology (CPACT), UK industry and academia.
大多数药物尤其是口服固体剂型和片剂。每个片剂的构件包括活性成分(或药物)和其他成分(赋形剂),这些成分(赋形剂)共同配制时,赋予稳定性,易于处理和给药,患者合规性,并确保每个片剂中的患者将正确剂量的药物递送给患者。这些成分通常以颗粒或粉末形式表示,无论是单个颗粒,聚集体还是配方中间体。该建议旨在将实验过程模拟器与高级测量相结合,以提高我们对颗粒原材料,压实过程以及结构以及结构和最终产品性能的结构和性质之间关系的理解。这将导致一系列进步,包括:预测或数字配方设计;快速过程开发;和数字制造。因此,这些进步将加速新药物可以达到市场并降低成本的速度,如果我们要意识到供应链以满足患者的未来药物需求,这是必要的。NEWPharmaceutical产品比可以在简单的非处方药中可以找到的标准立即释放片更为复杂。鉴于需要实现片剂的目标物理化学和生物制药特性,因此当今药物的开发和制造本身就是输入材料的分子和物理性能更复杂的函数。这种新分子化学的进步令人惊讶,而基于用于制定和生产它们的制造方法的科学对于任何给定的配方来说仍然不太了解。这需要新的方法和技术来在制造过程中访问化学和物理性能相关的材料特性。我们将通过将最新的Terahertz Tierahertz Time域光谱范围整合到高端压实模拟器中,以推动现有技术的限制。该完全集成的系统将能够使用Terahertz技术在压实过程中监测颗粒材料的物理和化学变化。该系统将提供一个创新且强大的研究平台,以应对药物科学和制造业中的关键研究挑战:压缩过程中药品材料的相变(主题1),对配方系统下的散装系统的现场监测(主题2),数字化药品的数字设计(主题3)。这些研究主题的结果范围从预测药物稳定性(主题1)以及通过快速配方设计(主题2)进行直接压缩到基于数字过程和产品设计的药物性能(主题3)。该设备将安置在一个由良好的学术和支持人员团队支持的管理良好,最先进的实验室设施中。该设备将为Strathclyde和其他英国学者提供激动人心的机会,与其他具有互补分析设施和制造过程的世界领先的团体合作并合作,从而创建了国际非剥夺跨国访问设施的国际协作网络。此外,该设备将与国家物理实验室(NPL),药品制造创新中心(MMIC),工艺分析与控制技术中心(CPACT),英国行业和学术界合作,为高价值制造,尖端测量技术和高级材料科学生成新的研究机会。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effect of Microsphere Concentration and Size in Compacts on Terahertz Scattering
压坯中微球浓度和尺寸对太赫兹散射的影响
- DOI:10.23919/eumc50147.2022.9784372
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Murphy K
- 通讯作者:Murphy K
Polymer Pellet Fabrication for Accurate THz-TDS Measurements
用于精确 THz-TDS 测量的聚合物颗粒制造
- DOI:10.3390/app12073475
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Murphy K
- 通讯作者:Murphy K
Observation of Spurious Spectral Features in Mixed-Powder Compressed Pellets Measured by Terahertz Time-Domain Spectroscopy
太赫兹时域光谱测量混合粉末压缩颗粒中杂散光谱特征的观察
- DOI:10.1109/tthz.2023.3290118
- 发表时间:2023
- 期刊:
- 影响因子:3.2
- 作者:Murphy K
- 通讯作者:Murphy K
Observation of spurious spectral features in mixed-powder compressed pellets measured by terahertz time-domain spectroscopy.
通过太赫兹时域光谱测量混合粉末压缩颗粒中的杂散光谱特征的观察。
- DOI:10.36227/techrxiv.22692448
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Nfataly M
- 通讯作者:Nfataly M
Analysis of THz Scattering of Compacted Granular Materials using THz-TDS
使用 THz-TDS 分析压实颗粒材料的太赫兹散射
- DOI:10.1109/irmmw-thz50927.2022.9895792
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Murphy K
- 通讯作者:Murphy K
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alastair Florence其他文献
Probing the interplay between drug saturation, processing temperature and microstructure of amorphous solid dispersions with synchrotron X-ray phase-contrast tomography
- DOI:
10.1016/j.ijpharm.2024.125018 - 发表时间:
2025-01-25 - 期刊:
- 影响因子:
- 作者:
Ecaterina Bordos;Gunjan Das;Sven L.M. Schroeder;Alastair Florence;Gavin W. Halbert;John Robertson - 通讯作者:
John Robertson
Comparative studies of powder flow predictions using milligrams of powder for identifying powder flow issues
- DOI:
10.1016/j.ijpharm.2022.122309 - 发表时间:
2022-11-25 - 期刊:
- 影响因子:
- 作者:
Tong Deng;Vivek Garg;Laura Pereira Diaz;Daniel Markl;Cameron Brown;Alastair Florence;Michael S.A. Bradley - 通讯作者:
Michael S.A. Bradley
Effect of oscillatory flow conditions on crystalliser fouling investigated through non-invasive imaging
- DOI:
10.1016/j.ces.2021.117188 - 发表时间:
2022-04-28 - 期刊:
- 影响因子:
- 作者:
Rachel Sheridan;Javier Cardona;Christos Tachtatzis;Yi-Chieh Chen;Alison Cleary;Naomi Briggs;Alastair Florence;Robert Atkinson;Craig Michie;Ivan Andonovic;Jan Sefcik - 通讯作者:
Jan Sefcik
Emerging Applications and Regulatory Strategies for Advanced Medicines Manufacturing - Towards the Development of a Platform Approach.
先进药品制造的新兴应用和监管策略 - 致力于开发平台方法。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
J. Srai;Paul Bauer;C. Badman;Massimo Bresciani;Charles L. Cooney;Alastair Florence;Doug Hausner;Konstantin Konstantinov;Sau L. Lee;Salvatore Mascia;Moheb Nasr;B. Trout - 通讯作者:
B. Trout
A hybrid system of mixture models for the prediction of particle size and shape, density, and flowability of pharmaceutical powder blends
- DOI:
10.1016/j.ijpx.2024.100298 - 发表时间:
2024-12-01 - 期刊:
- 影响因子:
- 作者:
Mohammad Salehian;Jonathan Moores;Jonathan Goldie;Isra' Ibrahim;Carlota Mendez Torrecillas;Ishwari Wale;Faisal Abbas;Natalie Maclean;John Robertson;Alastair Florence;Daniel Markl - 通讯作者:
Daniel Markl
Alastair Florence的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alastair Florence', 18)}}的其他基金
Digital Design and Manufacture of Amorphous Pharmaceuticals (DDMAP)
无定形药物的数字化设计与制造(DDMAP)
- 批准号:
EP/W003295/1 - 财政年份:2022
- 资助金额:
$ 66.19万 - 项目类别:
Research Grant
Made Smarter Innovation - Digital Medicines Manufacturing Research Centre
更智能的创新 - 数字药品制造研究中心
- 批准号:
EP/V062077/1 - 财政年份:2021
- 资助金额:
$ 66.19万 - 项目类别:
Research Grant
Future Continuous Manufacturing and Advanced Crystallisation Research Hub
未来连续制造和先进结晶研究中心
- 批准号:
EP/P006965/1 - 财政年份:2017
- 资助金额:
$ 66.19万 - 项目类别:
Research Grant
Development of an Innovative Modular System for Continuous Chemical Processing
开发连续化学处理的创新模块化系统
- 批准号:
EP/K504117/1 - 财政年份:2013
- 资助金额:
$ 66.19万 - 项目类别:
Research Grant
EPSRC Centre for Innovative Manufacturing for Continuous Manufacturing and Crystallisation
EPSRC 连续制造和结晶创新制造中心
- 批准号:
EP/I033459/1 - 财政年份:2011
- 资助金额:
$ 66.19万 - 项目类别:
Research Grant
相似国自然基金
新型激活依赖性分泌XCL1和IFNα的CAR-NK细胞通过介导肿瘤原位疫苗克服靶抗原异质性的作用及机制研究
- 批准号:82373302
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
活性材料表面功能分子嫁接与原位转化降低锂电对电解液和添加剂的依赖性
- 批准号:22179090
- 批准年份:2021
- 资助金额:60.00 万元
- 项目类别:面上项目
活性材料表面功能分子嫁接与原位转化降低锂电对电解液和添加剂的依赖性
- 批准号:
- 批准年份:2021
- 资助金额:60 万元
- 项目类别:面上项目
距离依赖性荧光纳米银簇探针的制备、荧光增强机理研究及生物分析新方法设计
- 批准号:21675052
- 批准年份:2016
- 资助金额:65.0 万元
- 项目类别:面上项目
溶剂依赖的石墨界面过程及其储钠行为的原位研究
- 批准号:21603175
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Evaluating Mechanisms and Therapeutic Potential of (GLP-1R) Agonists for Glaucoma Treatment
评估 (GLP-1R) 激动剂治疗青光眼的机制和治疗潜力
- 批准号:
10660124 - 财政年份:2023
- 资助金额:
$ 66.19万 - 项目类别:
Targeting The GLP-1 Receptor As New Chronotherapy Against Nondipping Blood Pressure In Diabetes
靶向 GLP-1 受体作为对抗糖尿病非下降血压的新计时疗法
- 批准号:
10672174 - 财政年份:2022
- 资助金额:
$ 66.19万 - 项目类别:
Mitochondria Dysfunction as a Contributor to Racial Disparities in Vascular Health and Hypertension
线粒体功能障碍导致血管健康和高血压的种族差异
- 批准号:
10515262 - 财政年份:2022
- 资助金额:
$ 66.19万 - 项目类别:
Targeting The GLP-1 Receptor As New Chronotherapy Against Nondipping Blood Pressure In Diabetes
靶向 GLP-1 受体作为对抗糖尿病非下降血压的新计时疗法
- 批准号:
10387235 - 财政年份:2022
- 资助金额:
$ 66.19万 - 项目类别:
Decipher Mechano-Chemo-Transduction Pathway and Function in Cardiomyocytes
破译心肌细胞中的机械化学传导途径和功能
- 批准号:
10317392 - 财政年份:2021
- 资助金额:
$ 66.19万 - 项目类别: